EDESA BIOTECH, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
EDESA BIOTECH, INC. (EDSA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $3.10 per share for the 12-month period ending 2024-09-30, per its 10-K filed 2024-12-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2025-12-12
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2015-12-31 was 9.42 CAD/shares, a 29.86% decline year-over-year.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2014-12-31 was 13.43 CAD/shares, a 801.34% increase year-over-year.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2013-12-31 was 1.49 CAD/shares.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2015 was 11.72 CAD/shares, a 25.82% decline from fiscal 2014.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2014 was 15.80 CAD/shares, a 315.79% increase from fiscal 2013.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2013 was 3.80 CAD/shares.
CAD/shares
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|---|---|
| 2016-03-31 | 9.42 CAD/shares 10-Q · filed 2016-05-09 | |||||
| 2015-12-31 | 9.42 CAD/shares 10-Q · filed 2016-02-08 | |||||
| 2015-09-30 | 11.72 CAD/shares 10-K · filed 2015-12-14 | |||||
| 2015-06-30 | 1.17 CAD/shares 10-Q · filed 2015-08-10 | |||||
| 2015-03-31 | 13.43 CAD/shares 10-Q · filed 2016-05-09 | 1.34 CAD/shares 10-Q · filed 2015-05-11 | ||||
| 2014-12-31 | 13.43 CAD/shares 10-Q · filed 2016-02-08 | 1.34 CAD/shares 10-Q · filed 2015-02-09 | ||||
| 2014-08-31 | 15.80 CAD/shares 10-K · filed 2015-12-14 | |||||
| 2014-06-30 | 1.51 CAD/shares 10-Q · filed 2015-08-10 | |||||
| 2014-03-31 | 1.51 CAD/shares 10-Q · filed 2015-05-11 | |||||
| 2013-12-31 | 1.49 CAD/shares 10-Q · filed 2015-02-09 | |||||
| 2013-08-31 | 3.80 CAD/shares 10-K · filed 2015-12-14 |
USD/shares
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-09-30 | $3.10 10-K · filed 2024-12-13 | ||||||
| 2024-06-30 | $3.10 10-Q · filed 2025-08-08 | ||||||
| 2024-03-31 | $3.10 10-Q · filed 2025-05-14 | ||||||
| 2023-12-31 | $3.10 10-Q · filed 2025-02-14 | ||||||
| 2023-09-30 | $3.10 10-K · filed 2025-12-12 | $5.23 10-K · filed 2024-12-13 | |||||
| 2023-06-30 | $7.49 10-Q · filed 2024-08-09 | ||||||
| 2022-12-31 | $0.71 10-Q · filed 2023-02-10 | ||||||
| 2019-03-31 | $1.20 10-Q · filed 2019-05-08 | ||||||
| 2018-09-30 | $5.67 10-K · filed 2018-11-30 | ||||||
| 2018-06-30 | $5.67 10-Q · filed 2018-08-08 | ||||||
| 2018-03-31 | $5.67 10-Q · filed 2019-05-08 | ||||||
| 2017-09-30 | $12.88 10-K · filed 2018-11-30 | $1.84 10-K · filed 2017-12-01 | |||||
| 2017-06-30 | $12.88 10-Q · filed 2018-08-08 | $1.84 10-Q · filed 2017-08-09 | |||||
| 2017-03-31 | $12.88 10-Q · filed 2018-05-07 | $1.84 10-Q · filed 2017-05-09 | |||||
| 2016-12-31 | $1.98 10-Q · filed 2018-02-07 | ||||||
| 2016-09-30 | $5.56 10-K · filed 2017-12-01 | ||||||
| 2016-06-30 | $7.08 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | $6.75 10-Q · filed 2017-05-09 | ||||||
| 2015-12-31 | $7.06 10-Q · filed 2017-02-06 | ||||||
| 2015-09-30 | $9.48 10-K · filed 2017-12-01 | ||||||
| 2015-06-30 | $9.76 10-Q · filed 2016-08-09 | ||||||
| 2014-08-31 | $15.14 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |